Newsletter | February 13, 2024

02.13.24 -- How Does Continuous Manufacturing Impact Clinical Supply?

SPONSOR

It is essential for pharmaceutical companies to evaluate many factors when choosing a clinical supply chain partner. With today’s global focus on vaccine development, the need for excellence in clinical cold chain distribution and storage has never been more acute. When selecting a supply chain partner, due diligence is critical. Read the article to review questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.

FEATURED EDITORIAL

How Does Continuous Manufacturing Impact Clinical Supply?

This overview article takes a look at each product development stage for bio/pharmaceuticals to illuminate when continuous manufacturing can satisfy important business drivers.

INDUSTRY INSIGHTS

A Risk-Based Approach To Injectable Combination Product Development

Examine how to establish a holistic approach to drug-device combination product (DDCP) development and how to assess and manage risk throughout the development and approval process.

Designing An Optimal APAC Clinical Supply Chain

Learn how to navigate the complex clinical supply distribution landscape within this important and growing region.

Creating Accurate, Efficient, And Effective CDMO Project Proposals

To receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.

Addressing Rare Disease Drug Product Manufacturing Challenges

Handling development and manufacturing challenges for orphan drugs requires experience, expertise, and scalable technologies, along with a flexible and agile supply chain.

SOLUTIONS

Innovations In IRT

Re-Imagining IRT For Modern Clinical Development

Blinded Randomization And Trial Supply Management Gets Support